25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Aminologics Co.Ltd
Buy, Hold or Sell?

Let's analyze Aminologics together

I guess you are interested in Aminologics Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aminologics Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Aminologics Co.Ltd

I send you an email if I find something interesting about Aminologics Co.Ltd.

1. Quick Overview

1.1. Quick analysis of Aminologics (30 sec.)










1.2. What can you expect buying and holding a share of Aminologics? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩595.57
Expected worth in 1 year
₩629.86
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
₩34.29
Return On Investment
3.4%

For what price can you sell your share?

Current Price per Share
₩1,018.00
Expected price per share
₩982.00 - ₩1,216
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Aminologics (5 min.)




Live pricePrice per Share (EOD)
₩1,018.00

2.2. Growth of Aminologics (5 min.)




Is Aminologics growing?

Current yearPrevious yearGrowGrow %
How rich?$39.2m$39m-$744.2k-1.9%

How much money is Aminologics making?

Current yearPrevious yearGrowGrow %
Making money$496.4k-$1.7m$2.2m456.8%
Net Profit Margin10.4%-41.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Aminologics (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Aminologics?

Welcome investor! Aminologics's management wants to use your money to grow the business. In return you get a share of Aminologics.

First you should know what it really means to hold a share of Aminologics. And how you can make/lose money.

Speculation

The Price per Share of Aminologics is ₩1,018. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aminologics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aminologics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩595.57. Based on the TTM, the Book Value Change Per Share is ₩8.57 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-28.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aminologics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%0.010.0%-0.020.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.010.0%-0.020.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.010.0%-0.020.0%0.000.0%0.000.0%
Usd Price Per Share0.93-0.96-1.26-1.43-1.42-
Price to Earnings Ratio69.02-15.75-62.59-2,101.74-1,096.38-
Price-to-Total Gains Ratio510.18-78.00-227.58-9,225.50-4,782.23-
Price to Book Ratio2.22-2.36-3.07-3.44-3.87-
Price-to-Total Gains Ratio510.18-78.00-227.58-9,225.50-4,782.23-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7126
Number of shares1403
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (1403 shares)8.420.72
Gains per Year (1403 shares)33.672.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10342403-7
20675806-4
301019209-1
401351260112
501681600145
602021940178
7023622802011
8026926202314
9030329602617
10033733002920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%29.06.05.072.5%29.06.010.064.4%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%29.011.00.072.5%31.014.00.068.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.045.00.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%29.011.00.072.5%31.014.00.068.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Aminologics Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.5978.572-70%-28.654+1203%0.729+256%4.665-44%
Book Value Per Share--595.571581.223+2%592.527+1%593.977+0%531.165+12%
Current Ratio--11.64213.409-13%12.044-3%9.600+21%6.686+74%
Debt To Asset Ratio--0.0820.071+16%0.070+17%0.0820%0.095-14%
Debt To Equity Ratio--0.0890.076+17%0.076+18%0.0900%0.106-16%
Dividend Per Share----0%-0%-0%-0%
Eps--4.7997.540-36%-26.903+661%0.922+420%4.002+20%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Market Cap95752575072.000-30%124628842800.000129190728744.000-4%169260077448.000-26%192455151134.400-35%191239432045.200-35%
Net Profit Margin--0.0830.104-20%-0.417+603%0.006+1304%0.073+14%
Operating Margin----0%0.062-100%0.105-100%0.102-100%
Operating Ratio--1.4211.520-7%1.198+19%0.973+46%1.029+38%
Pb Ratio1.709-30%2.2252.362-6%3.065-27%3.437-35%3.871-43%
Pe Ratio53.031-30%69.02415.747+338%62.593+10%2101.744-97%1096.377-94%
Price Per Share1018.000-30%1325.0001373.500-4%1799.500-26%2046.100-35%2033.175-35%
Price To Free Cash Flow Ratio----16.6920%-14.4360%-2.9070%-4.5690%
Price To Total Gains Ratio391.974-30%510.18278.003+554%227.580+124%9225.497-94%4782.232-89%
Quick Ratio---5.337-100%14.294-100%9.291-100%5.799-100%
Return On Assets--0.0070.012-38%-0.048+749%0.000+106%0.006+25%
Return On Equity--0.0080.013-37%-0.052+747%-0.001+106%0.007+23%
Total Gains Per Share--2.5978.572-70%-28.654+1203%0.729+256%4.665-44%
Usd Book Value--39213399.40038268699.499+2%39012958.185+1%39108420.804+0%34972777.908+12%
Usd Book Value Change Per Share--0.0020.006-70%-0.020+1203%0.001+256%0.003-44%
Usd Book Value Per Share--0.4170.407+2%0.415+1%0.416+0%0.372+12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0030.005-36%-0.019+661%0.001+420%0.003+20%
Usd Free Cash Flow---621364.139-100%242547.001-100%501939.542-100%697853.218-100%
Usd Market Cap67026802.550-30%87240189.96090433510.121-4%118482054.214-26%134718605.794-35%133867602.432-35%
Usd Price Per Share0.713-30%0.9280.961-4%1.260-26%1.432-35%1.423-35%
Usd Profit--315977.200496417.675-36%-1771346.106+661%60737.207+420%263523.323+20%
Usd Revenue--3808141.4003965931.230-4%3896400.065-2%3785209.033+1%3198112.740+19%
Usd Total Gains Per Share--0.0020.006-70%-0.020+1203%0.001+256%0.003-44%
 EOD+3 -4MRQTTM+7 -20YOY+16 -125Y+20 -810Y+17 -12

3.3 Fundamental Score

Let's check the fundamental score of Aminologics Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1553.031
Price to Book Ratio (EOD)Between0-11.709
Net Profit Margin (MRQ)Greater than00.083
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than111.642
Debt to Asset Ratio (MRQ)Less than10.082
Debt to Equity Ratio (MRQ)Less than10.089
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.007
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Aminologics Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.169
Ma 20Greater thanMa 501,090.100
Ma 50Greater thanMa 1001,149.200
Ma 100Greater thanMa 2001,225.030
OpenGreater thanClose1,016.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Aminologics Co.Ltd

Aminologics Co.,Ltd., a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries in South Korea. Its products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, 4-chloro-D-phenylalanine, 3-(2-napthyl)-L-alanine, R-beta-phenylalanine, D-leucine, D-valine, 4-chloro-L-phenylalanine, D-histidine, Fmoc-D-allo-isoleucine, Fmoc-D-alanine, and Fmoc-D-phenylalanine. The company's products also comprise Boc-D-phenylalanine, L-homophenylalanine, D-homophenylalanine, 3-(3-pyridyl)-L-alanine, 3-(3-pyridyl)-D-alanine, D-cysteine HCL H2O, D-serine methyl ester HCl, Boc-D-Ser-OH, D-threonine, Fmoc-D-Leu-OH, Boc-D-4-Benzoylphenylalanine, Fmoc-D-Cyclohexylalanine, Fmoc-D-Pentafluorophenylalanine, Fmoc-D-Trp(Boc)-OH, Fmoc-L-Trp(Boc)-OH, Fmoc-D-Ser(tBu)-OH, and Fmoc-L-Ser(tBu)-OH. In addition, it operates resort and power generation businesses. Aminologics Co.,Ltd. was founded in 1997 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 19:05:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Aminologics earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Aminologics to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 8.3% means that ₩0.08 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aminologics Co.Ltd:

  • The MRQ is 8.3%. The company is making a profit. +1
  • The TTM is 10.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ8.3%TTM10.4%-2.1%
TTM10.4%YOY-41.7%+52.1%
TTM10.4%5Y0.6%+9.8%
5Y0.6%10Y7.3%-6.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3%9.8%-1.5%
TTM10.4%9.5%+0.9%
YOY-41.7%9.9%-51.6%
5Y0.6%12.9%-12.3%
10Y7.3%12.6%-5.3%
4.3.1.2. Return on Assets

Shows how efficient Aminologics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aminologics to the Pharmaceuticals industry mean.
  • 0.7% Return on Assets means that Aminologics generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aminologics Co.Ltd:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.7%TTM1.2%-0.4%
TTM1.2%YOY-4.8%+6.0%
TTM1.2%5Y0.0%+1.2%
5Y0.0%10Y0.6%-0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%3.6%-2.9%
TTM1.2%3.5%-2.3%
YOY-4.8%5.3%-10.1%
5Y0.0%5.9%-5.9%
10Y0.6%4.9%-4.3%
4.3.1.3. Return on Equity

Shows how efficient Aminologics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aminologics to the Pharmaceuticals industry mean.
  • 0.8% Return on Equity means Aminologics generated ₩0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aminologics Co.Ltd:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.3%-0.5%
TTM1.3%YOY-5.2%+6.5%
TTM1.3%5Y-0.1%+1.3%
5Y-0.1%10Y0.7%-0.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%4.6%-3.8%
TTM1.3%4.6%-3.3%
YOY-5.2%8.2%-13.4%
5Y-0.1%9.1%-9.2%
10Y0.7%10.3%-9.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Aminologics Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Aminologics is operating .

  • Measures how much profit Aminologics makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aminologics to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aminologics Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.2%-6.2%
TTM-5Y10.5%-10.5%
5Y10.5%10Y10.2%+0.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY6.2%12.4%-6.2%
5Y10.5%8.6%+1.9%
10Y10.2%12.1%-1.9%
4.3.2.2. Operating Ratio

Measures how efficient Aminologics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.42 means that the operating costs are ₩1.42 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Aminologics Co.Ltd:

  • The MRQ is 1.421. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.520. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.421TTM1.520-0.099
TTM1.520YOY1.198+0.321
TTM1.5205Y0.973+0.547
5Y0.97310Y1.029-0.056
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4211.225+0.196
TTM1.5201.220+0.300
YOY1.1981.311-0.113
5Y0.9731.249-0.276
10Y1.0291.240-0.211
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Aminologics Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Aminologics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 11.64 means the company has ₩11.64 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Aminologics Co.Ltd:

  • The MRQ is 11.642. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.409. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.642TTM13.409-1.766
TTM13.409YOY12.044+1.365
TTM13.4095Y9.600+3.809
5Y9.60010Y6.686+2.914
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6422.213+9.429
TTM13.4092.234+11.175
YOY12.0442.028+10.016
5Y9.6002.199+7.401
10Y6.6861.995+4.691
4.4.3.2. Quick Ratio

Measures if Aminologics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aminologics to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aminologics Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.337-5.337
TTM5.337YOY14.294-8.957
TTM5.3375Y9.291-3.954
5Y9.29110Y5.799+3.492
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM5.3370.973+4.364
YOY14.2941.515+12.779
5Y9.2911.591+7.700
10Y5.7991.399+4.400
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Aminologics Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Aminologics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aminologics to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.08 means that Aminologics assets are financed with 8.2% credit (debt) and the remaining percentage (100% - 8.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aminologics Co.Ltd:

  • The MRQ is 0.082. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.071. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.082TTM0.071+0.011
TTM0.071YOY0.070+0.001
TTM0.0715Y0.082-0.011
5Y0.08210Y0.095-0.013
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0820.345-0.263
TTM0.0710.339-0.268
YOY0.0700.333-0.263
5Y0.0820.315-0.233
10Y0.0950.339-0.244
4.5.4.2. Debt to Equity Ratio

Measures if Aminologics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aminologics to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 8.9% means that company has ₩0.09 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aminologics Co.Ltd:

  • The MRQ is 0.089. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.076. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.076+0.013
TTM0.076YOY0.076+0.001
TTM0.0765Y0.090-0.014
5Y0.09010Y0.106-0.016
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0890.547-0.458
TTM0.0760.547-0.471
YOY0.0760.499-0.423
5Y0.0900.476-0.386
10Y0.1060.548-0.442
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Aminologics generates.

  • Above 15 is considered overpriced but always compare Aminologics to the Pharmaceuticals industry mean.
  • A PE ratio of 69.02 means the investor is paying ₩69.02 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aminologics Co.Ltd:

  • The EOD is 53.031. Based on the earnings, the company is expensive. -2
  • The MRQ is 69.024. Based on the earnings, the company is expensive. -2
  • The TTM is 15.747. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD53.031MRQ69.024-15.993
MRQ69.024TTM15.747+53.277
TTM15.747YOY62.593-46.846
TTM15.7475Y2,101.744-2,085.997
5Y2,101.74410Y1,096.377+1,005.367
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD53.03127.863+25.168
MRQ69.02429.844+39.180
TTM15.74727.532-11.785
YOY62.59323.102+39.491
5Y2,101.74427.577+2,074.167
10Y1,096.37729.248+1,067.129
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aminologics Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-16.692+16.692
TTM-16.692YOY-14.436-2.256
TTM-16.6925Y-2.907-13.785
5Y-2.90710Y-4.569+1.662
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-16.69229.447-46.139
YOY-14.43626.360-40.796
5Y-2.90731.734-34.641
10Y-4.56934.357-38.926
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Aminologics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 2.22 means the investor is paying ₩2.22 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Aminologics Co.Ltd:

  • The EOD is 1.709. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.225. Based on the equity, the company is underpriced. +1
  • The TTM is 2.362. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.709MRQ2.225-0.515
MRQ2.225TTM2.362-0.137
TTM2.362YOY3.065-0.704
TTM2.3625Y3.437-1.075
5Y3.43710Y3.871-0.434
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD1.7094.659-2.950
MRQ2.2253.381-1.156
TTM2.3623.209-0.847
YOY3.0652.597+0.468
5Y3.4373.278+0.159
10Y3.8714.179-0.308
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets61,029,292
Total Liabilities5,010,150
Total Stockholder Equity56,019,141
 As reported
Total Liabilities 5,010,150
Total Stockholder Equity+ 56,019,141
Total Assets = 61,029,292

Assets

Total Assets61,029,292
Total Current Assets48,466,796
Long-term Assets12,562,496
Total Current Assets
Total Current Assets  (as reported)48,466,796
Total Current Assets  (calculated)0
+/- 48,466,796
Long-term Assets
Long-term Assets  (as reported)12,562,496
Long-term Assets  (calculated)0
+/- 12,562,496

Liabilities & Shareholders' Equity

Total Current Liabilities4,162,987
Long-term Liabilities847,163
Total Stockholder Equity56,019,141
Total Current Liabilities
Total Current Liabilities  (as reported)4,162,987
Total Current Liabilities  (calculated)0
+/- 4,162,987
Long-term Liabilities
Long-term Liabilities  (as reported)847,163
Long-term Liabilities  (calculated)0
+/- 847,163
Total Stockholder Equity
Total Stockholder Equity (as reported)56,019,141
Total Stockholder Equity (calculated)0
+/- 56,019,141
Other
Common Stock Shares Outstanding 87,827
Net Invested Capital 56,019,141
Net Working Capital 44,303,809



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
62,024,040
47,984,765
41,305,086
48,204,720
46,774,055
45,146,369
44,472,575
38,630,498
35,185,825
30,972,871
32,862,455
55,027,043
55,285,083
54,713,473
53,612,789
49,025,731
49,193,553
50,265,186
49,774,043
49,371,249
51,142,697
52,904,390
53,578,999
56,858,958
61,012,443
60,840,711
60,599,246
57,773,776
57,174,071
57,915,670
58,737,099
60,128,523
59,465,270
65,155,673
64,144,432
65,242,517
68,259,029
67,489,194
69,870,657
55,582,184
56,714,107
57,330,227
56,271,902
57,668,069
60,438,819
61,029,292
61,029,29260,438,81957,668,06956,271,90257,330,22756,714,10755,582,18469,870,65767,489,19468,259,02965,242,51764,144,43265,155,67359,465,27060,128,52358,737,09957,915,67057,174,07157,773,77660,599,24660,840,71161,012,44356,858,95853,578,99952,904,39051,142,69749,371,24949,774,04350,265,18649,193,55349,025,73153,612,78954,713,47355,285,08355,027,04332,862,45530,972,87135,185,82538,630,49844,472,57545,146,36946,774,05548,204,72041,305,08647,984,76562,024,040
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,290,987
27,875,128
27,986,690
29,607,008
31,425,174
32,135,440
31,897,865
35,032,945
35,397,188
35,533,100
32,491,431
33,209,843
33,783,554
34,767,448
35,324,798
33,890,287
37,228,947
36,067,400
38,679,494
41,609,368
41,465,357
44,252,107
43,569,080
40,389,979
39,861,110
39,717,277
45,248,837
47,202,211
48,466,796
48,466,79647,202,21145,248,83739,717,27739,861,11040,389,97943,569,08044,252,10741,465,35741,609,36838,679,49436,067,40037,228,94733,890,28735,324,79834,767,44833,783,55433,209,84332,491,43135,533,10035,397,18835,032,94531,897,86532,135,44031,425,17429,607,00827,986,69027,875,12828,290,98700000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,442,505
6,810,230
7,469,424
9,666,800
9,484,929
11,333,862
11,676,897
13,220,807
6,744,198
7,392,219
8,140,660
7,877,642
8,063,643
6,910,497
8,580,320
6,390,619
7,323,935
9,114,707
13
13
1,954
303
14
14
14
8,566,424
11,998,628
17,221,438
0
017,221,43811,998,6288,566,4241414143031,95413139,114,7077,323,9356,390,6198,580,3206,910,4978,063,6437,877,6428,140,6607,392,2196,744,19813,220,80711,676,89711,333,8629,484,9299,666,8007,469,4246,810,2306,442,50500000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000,000
10,064,667
10,064,667
10,132,598
10,132,598
10,211,239
10,211,239
10,256,084
16,256,084
16,300,000
0
0
0
16,801,454
16,802,623
16,804,136
16,805,122
16,801,232
16,802,038
16,803,295
16,804,607
16,500,000
16,500,000
16,500,000
16,500,000
16,500,000
16,500,000
16,500,000
0
016,500,00016,500,00016,500,00016,500,00016,500,00016,500,00016,500,00016,804,60716,803,29516,802,03816,801,23216,805,12216,804,13616,802,62316,801,45400016,300,00016,256,08410,256,08410,211,23910,211,23910,132,59810,132,59810,064,66710,064,66710,000,00000000000000000000
       Net Receivables 
3,131,270
821,828
522,434
1,619,153
1,028,396
1,643,547
1,288,733
1,418,407
894,799
1,263,710
3,137,094
4,042,701
4,120,295
4,865,784
4,412,197
4,392,650
4,250,233
4,944,848
4,607,205
4,834,339
4,048,753
5,853,482
4,223,762
4,828,116
5,709,123
5,839,165
4,228,151
4,117,207
4,940,725
4,510,884
6,418,815
4,789,914
4,965,855
6,838,926
4,225,213
6,489,100
7,669,573
3,450,950
6,249,660
5,539,292
3,420,025
4,043,453
3,980,599
8,241,204
4,702,671
0
04,702,6718,241,2043,980,5994,043,4533,420,0255,539,2926,249,6603,450,9507,669,5736,489,1004,225,2136,838,9264,965,8554,789,9146,418,8154,510,8844,940,7254,117,2074,228,1515,839,1655,709,1234,828,1164,223,7625,853,4824,048,7534,834,3394,607,2054,944,8484,250,2334,392,6504,412,1974,865,7844,120,2954,042,7013,137,0941,263,710894,7991,418,4071,288,7331,643,5471,028,3961,619,153522,434821,8283,131,270
       Other Current Assets 
392,533
452,635
396,210
195,199
283,103
174,506
148,226
99,964
392,007
127,452
1,103,351
1,487,113
71,266
46,649
82,636
56,546
32,711
50,112
28,155
78,865
53,969
26,957
45,436
49,994
63,867
25,351
53,920
120,748
379,429
333,297
63,897
48,019
52,167
13,098
148,783
69,700
31,336
317,045
42,661
-2,012,245
-2,057,242
-2,068,335
0
1
0
0
0010-2,068,335-2,057,242-2,012,24542,661317,04531,33669,700148,78313,09852,16748,01963,897333,297379,429120,74853,92025,35163,86749,99445,43626,95753,96978,86528,15550,11232,71156,54682,63646,64971,2661,487,1131,103,351127,452392,00799,964148,226174,506283,103195,199396,210452,635392,533
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,013,104
16,324,128
17,469,117
16,554,625
12,419,232
13,236,608
12,562,496
12,562,49613,236,60812,419,23216,554,62517,469,11716,324,12812,013,104000000000000000000000000000000000000000
       Property Plant Equipment 
1,025,405
855,250
816,129
800,424
763,033
710,349
686,218
647,240
608,676
570,443
532,448
495,150
467,898
430,478
393,178
349,141
313,380
277,993
242,607
461,823
684,773
653,763
623,817
618,863
1,513,516
1,506,805
1,468,991
1,437,885
1,380,695
1,468,519
1,639,161
1,585,153
2,081,323
2,032,011
2,099,053
2,119,952
2,118,645
2,188,494
2,109,245
2,825,874
2,807,098
2,728,461
2,709,660
2,629,958
2,950,624
0
02,950,6242,629,9582,709,6602,728,4612,807,0982,825,8742,109,2452,188,4942,118,6452,119,9522,099,0532,032,0112,081,3231,585,1531,639,1611,468,5191,380,6951,437,8851,468,9911,506,8051,513,516618,863623,817653,763684,773461,823242,607277,993313,380349,141393,178430,478467,898495,150532,448570,443608,676647,240686,218710,349763,033800,424816,129855,2501,025,405
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,373,868
1,373,868
1,440,802
1,440,802
1,440,802
1,440,802
4,961,176
5,085,967
4,568,315
4,231,753
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000004,231,7534,568,3155,085,9674,961,1761,440,8021,440,8021,440,8021,440,8021,373,8681,373,86800000000000000000
       Intangible Assets 
25,157,489
15,651,163
15,075,894
11,091,982
10,787,215
10,480,608
10,174,467
7,268,277
7,042,889
6,824,462
6,598,714
24,769,036
24,566,758
24,363,432
24,161,807
20,080,441
20,038,164
20,001,310
19,962,836
19,204,819
19,132,397
19,129,665
19,133,619
19,130,714
19,131,562
19,128,561
19,125,561
19,124,699
19,127,859
19,124,728
19,121,718
19,118,707
19,133,972
19,132,345
19,135,698
17,598,424
17,606,933
17,602,009
17,597,085
4,074,161
4,069,237
4,064,313
4,059,389
4,054,464
4,049,544
0
04,049,5444,054,4644,059,3894,064,3134,069,2374,074,16117,597,08517,602,00917,606,93317,598,42419,135,69819,132,34519,133,97219,118,70719,121,71819,124,72819,127,85919,124,69919,125,56119,128,56119,131,56219,130,71419,133,61919,129,66519,132,39719,204,81919,962,83620,001,31020,038,16420,080,44124,161,80724,363,43224,566,75824,769,0366,598,7146,824,4627,042,8897,268,27710,174,46710,480,60810,787,21511,091,98215,075,89415,651,16325,157,489
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,592
-1
0
0
0
000-114,59200000000000000000000000000000000000000000
> Total Liabilities 
17,496,645
15,160,102
10,380,413
7,780,618
7,050,319
6,680,247
6,853,634
6,783,668
4,227,296
3,751,147
5,206,859
6,751,782
6,520,204
5,832,118
4,396,265
4,477,973
4,016,806
4,889,591
4,112,206
4,228,824
5,030,379
5,169,779
4,887,712
3,671,083
6,669,415
6,192,829
5,950,265
5,922,039
5,755,025
5,583,364
5,691,583
6,570,658
5,038,071
6,184,210
4,211,618
5,849,409
5,639,724
3,914,554
3,717,317
4,178,089
4,134,344
4,536,235
3,798,629
3,257,060
4,663,960
5,010,150
5,010,1504,663,9603,257,0603,798,6294,536,2354,134,3444,178,0893,717,3173,914,5545,639,7245,849,4094,211,6186,184,2105,038,0716,570,6585,691,5835,583,3645,755,0255,922,0395,950,2656,192,8296,669,4153,671,0834,887,7125,169,7795,030,3794,228,8244,112,2064,889,5914,016,8064,477,9734,396,2655,832,1186,520,2046,751,7825,206,8593,751,1474,227,2966,783,6686,853,6346,680,2477,050,3197,780,61810,380,41315,160,10217,496,645
   > Total Current Liabilities 
16,462,250
14,179,894
9,397,852
6,799,968
6,061,946
5,710,123
5,892,166
5,810,110
3,252,198
2,986,619
4,420,021
5,932,842
5,675,219
4,970,891
3,516,396
3,575,997
3,081,794
3,940,659
3,132,663
3,204,070
3,960,694
4,065,512
3,753,728
2,478,697
4,703,982
5,412,847
5,148,975
5,241,885
5,074,871
4,980,795
5,128,168
6,046,638
4,425,187
5,652,062
3,725,278
5,381,382
5,218,800
3,442,172
3,295,280
3,428,599
3,433,567
3,879,417
3,182,205
2,667,525
3,761,560
4,162,987
4,162,9873,761,5602,667,5253,182,2053,879,4173,433,5673,428,5993,295,2803,442,1725,218,8005,381,3823,725,2785,652,0624,425,1876,046,6385,128,1684,980,7955,074,8715,241,8855,148,9755,412,8474,703,9822,478,6973,753,7284,065,5123,960,6943,204,0703,132,6633,940,6593,081,7943,575,9973,516,3964,970,8915,675,2195,932,8424,420,0212,986,6193,252,1985,810,1105,892,1665,710,1236,061,9466,799,9689,397,85214,179,89416,462,250
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
0
0
0
0
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
0
0
0
0
00001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,0001,000,00000001,000,0001,000,0001,000,0001,000,0001,000,00000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
1,000,000
0
01,000,0001,000,0001,000,0001,000,0001,000,0001,000,000000000000000000001,000,0001,000,0001,000,0001,000,0001,000,00000000000000000000
       Accounts payable 
241,793
324,250
127,033
244,853
227,980
0
202,073
2,816
356,175
207,877
1,872,232
2,217,689
2,006,511
2,518,671
2,376,981
2,239,174
1,825,547
2,742,338
1,918,679
1,919,964
2,729,519
2,848,169
2,538,594
1,131,090
3,351,723
2,931,371
2,752,314
2,693,562
2,466,074
2,510,639
2,692,989
3,578,273
2,921,437
4,212,121
2,026,181
3,674,273
2,496,649
1,753,453
1,704,355
1,549,877
1,608,151
2,225,243
1,503,816
648,713
1,946,064
0
01,946,064648,7131,503,8162,225,2431,608,1511,549,8771,704,3551,753,4532,496,6493,674,2732,026,1814,212,1212,921,4373,578,2732,692,9892,510,6392,466,0742,693,5622,752,3142,931,3713,351,7231,131,0902,538,5942,848,1692,729,5191,919,9641,918,6792,742,3381,825,5472,239,1742,376,9812,518,6712,006,5112,217,6891,872,232207,877356,1752,816202,0730227,980244,853127,033324,250241,793
       Other Current Liabilities 
3,242,347
2,855,644
2,776,148
2,805,607
2,083,966
1,960,123
1,940,093
2,057,294
1,896,023
1,778,742
1,547,789
2,715,153
2,668,708
1,452,220
139,415
336,823
256,247
198,321
213,984
284,106
231,175
187,287
180,473
236,273
199,807
1,356,898
1,293,099
1,348,126
1,446,491
1,270,599
1,226,079
1,151,448
233,832
105,438
363,955
362,012
1,275,587
267,766
178,458
0
0
0
0
0
1
0
0100000178,458267,7661,275,587362,012363,955105,438233,8321,151,4481,226,0791,270,5991,446,4911,348,1261,293,0991,356,898199,807236,273180,473187,287231,175284,106213,984198,321256,247336,823139,4151,452,2202,668,7082,715,1531,547,7891,778,7421,896,0232,057,2941,940,0931,960,1232,083,9662,805,6072,776,1482,855,6443,242,347
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
749,491
700,777
656,818
616,424
589,535
902,400
847,163
847,163902,400589,535616,424656,818700,777749,491000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
801,290
680,155
680,155
602,569
563,415
524,020
612,884
532,149
486,339
468,027
420,925
472,382
422,037
749,491
700,777
656,818
0
0
0
0
0000656,818700,777749,491422,037472,382420,925468,027486,339532,149612,884524,020563,415602,569680,155680,155801,29000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
0
0
0
0
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-1,000,000
-10,921
-73,031
-133,593
853,445
818,956
1,186,062
0
01,186,062818,956853,445-133,593-73,031-10,921-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,0000000-1,000,000-1,000,000-1,000,000-1,000,000-1,000,00000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,895
41,002
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000041,00242,89500000000000000000
> Total Stockholder Equity
44,556,378
32,824,662
30,924,673
40,424,102
39,723,735
38,466,122
37,618,941
31,846,831
30,958,528
27,221,724
27,655,597
48,275,261
48,764,879
48,881,355
49,216,523
44,547,758
45,176,747
45,375,595
45,661,836
45,142,425
46,112,318
47,734,611
48,691,287
53,187,874
54,343,028
54,647,881
54,648,981
51,851,737
51,419,046
52,332,307
53,045,515
53,557,865
54,427,199
58,971,462
59,932,814
59,393,108
62,619,305
63,574,640
66,153,340
51,404,094
52,579,763
52,793,992
52,473,273
54,411,009
55,774,859
56,019,141
56,019,14155,774,85954,411,00952,473,27352,793,99252,579,76351,404,09466,153,34063,574,64062,619,30559,393,10859,932,81458,971,46254,427,19953,557,86553,045,51552,332,30751,419,04651,851,73754,648,98154,647,88154,343,02853,187,87448,691,28747,734,61146,112,31845,142,42545,661,83645,375,59545,176,74744,547,75849,216,52348,881,35548,764,87948,275,26127,655,59727,221,72430,958,52831,846,83137,618,94138,466,12239,723,73540,424,10230,924,67332,824,66244,556,378
   Common Stock
6,027,732
6,027,732
6,027,732
7,325,232
7,325,232
7,325,232
7,325,232
7,325,232
7,325,232
7,325,232
7,325,232
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
8,782,684
0
0
0
0
00008,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6848,782,6847,325,2327,325,2327,325,2327,325,2327,325,2327,325,2327,325,2327,325,2326,027,7326,027,7326,027,732
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
117,918,806
0
0
0
0
0000117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,806117,918,80600000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
410,014
409,998
462,382
-213,339
-213,471
-213,448
-164,165
-164,211
-164,258
852,554
-299,460
-299,618
-299,563
-299,497
-733,298
-733,406
-733,397
-733,531
-257,887
-257,949
-258,154
-258,523
852,392
852,301
852,278
0
0
0
0
0000852,278852,301852,392-258,523-258,154-257,949-257,887-733,531-733,397-733,406-733,298-299,497-299,563-299,618-299,460852,554-164,258-164,211-164,165-213,448-213,471-213,339462,382409,998410,01400000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue20,886,623
Cost of Revenue-13,110,991
Gross Profit7,775,6327,775,632
 
Operating Income (+$)
Gross Profit7,775,632
Operating Expense-19,424,607
Operating Income1,462,016-11,648,975
 
Operating Expense (+$)
Research Development1,306,705
Selling General Administrative1,564,392
Selling And Marketing Expenses0
Operating Expense19,424,6072,871,097
 
Net Interest Income (+$)
Interest Income929,758
Interest Expense-57,077
Other Finance Cost-0
Net Interest Income872,681
 
Pretax Income (+$)
Operating Income1,462,016
Net Interest Income872,681
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,290,8501,462,016
EBIT - interestExpense = -57,077
2,436,163
2,493,240
Interest Expense57,077
Earnings Before Interest and Taxes (EBIT)02,347,927
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,290,850
Tax Provision--145,313
Net Income From Continuing Ops2,436,1632,436,163
Net Income2,436,163
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-872,681
 

Technical Analysis of Aminologics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aminologics. The general trend of Aminologics is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aminologics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aminologics Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,094 < 1,137 < 1,216.

The bearish price targets are: 982.00.

Tweet this
Aminologics Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aminologics Co.Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aminologics Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aminologics Co.Ltd. The current macd is -46.92883643.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aminologics price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Aminologics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Aminologics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Aminologics Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAminologics Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aminologics Co.Ltd. The current adx is 34.90.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Aminologics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Aminologics Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aminologics Co.Ltd. The current sar is 983.12.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Aminologics Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aminologics Co.Ltd. The current rsi is 30.17. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Aminologics Co.Ltd Daily Relative Strength Index (RSI) ChartAminologics Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aminologics Co.Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Aminologics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Aminologics Co.Ltd Daily Stochastic Oscillator ChartAminologics Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aminologics Co.Ltd. The current cci is -71.79391798.

Aminologics Co.Ltd Daily Commodity Channel Index (CCI) ChartAminologics Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aminologics Co.Ltd. The current cmo is -44.88110608.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aminologics Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartAminologics Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aminologics Co.Ltd. The current willr is -81.25.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Aminologics Co.Ltd Daily Williams %R ChartAminologics Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aminologics Co.Ltd.

Aminologics Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aminologics Co.Ltd. The current atr is 34.49.

Aminologics Co.Ltd Daily Average True Range (ATR) ChartAminologics Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aminologics Co.Ltd. The current obv is 248,680,333.

Aminologics Co.Ltd Daily On-Balance Volume (OBV) ChartAminologics Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aminologics Co.Ltd. The current mfi is 24.21.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Aminologics Co.Ltd Daily Money Flow Index (MFI) ChartAminologics Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aminologics Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Aminologics Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aminologics Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.169
Ma 20Greater thanMa 501,090.100
Ma 50Greater thanMa 1001,149.200
Ma 100Greater thanMa 2001,225.030
OpenGreater thanClose1,016.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Aminologics with someone you think should read this too:
  • Are you bullish or bearish on Aminologics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aminologics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aminologics Co.Ltd

I send you an email if I find something interesting about Aminologics Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Aminologics Co.Ltd.

Receive notifications about Aminologics Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.